| 今开：1.94 | 昨收：1.935 |
| 最高：1.9649 | 最低：1.9 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.353082E7 |
Exagen(XGN)05-17 08:05
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000052 Size: 5 KB 网页链接查看全文
Exagen(XGN)05-13 21:35
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-24-000048 Act: 34 Size: 4 MB 网页链接查看全文
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000062 Size: 5 KB 网页链接查看全文
Exagen(XGN)04-26 20:35
$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-24-000028 Act: 34 Size: 1 MB 网页链接查看全文
Exagen(XGN)04-26 21:25
$Exagen(XGN)$ ARS Annual Report to Security Holders Accession Number: 0001274737-24-000037 Act: 34 Size: 13 MB 网页链接查看全文
Exagen(XGN)05-13 20:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-24-000045 Act: 34 Size: 300 KB 网页链接查看全文
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000061 Size: 5 KB 网页链接查看全文
Exagen(XGN)06-12 04:15
$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-24-000056 Act: 34 Size: 159 KB 网页链接查看全文
Exagen(XGN)04-26 20:35
$Exagen(XGN)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001274737-24-000030 Act: 34 Size: 188 KB 网页链接查看全文
Exagen(XGN)06-13 04:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000063 Size: 5 KB 网页链接查看全文
蹊之美股生物医药2021-08-12 03:35
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001274737-23-000116 Act: 34 Size: 233 KB 网页链接
$Exagen(XGN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003493 Act: 33 Size: 1 KB 网页链接
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001628280-23-040240 Act: 33 Size: 435 KB 网页链接
$Exagen(XGN)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001274737-23-000111 Act: 33 Size: 625 KB 网页链接
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001274737-23-000108 Act: 33 Size: 91 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001274737-23-000105 Act: 34 Size: 18 MB 网页链接
$Exagen(XGN)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001628280-23-039459 Act: 33 Size: 699 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-23-000103 Act: 34 Size: 173 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-23-000101 Act: 34 Size: 321 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 1.01, 1.02, and 9.01 Accession Number: 0001274737-23-000096 Act: 34 Size: 158 KB 网页链接